Sign inJoin waitlistJoin the waitlist

Jeries Kort

Assistant Professor, Hematologic Malignancies and Cellular Therapeutics · University of Kansas School of Medicine

Credentials: · · · · · ·

History

University of Kansas School of Medicine
Present

Case Western Reserve University- Cleveland
2023–2026
American University of Beirut
2023–2026
Internal Medicine
Case Western Reserve University/University Hospitals Cleveland Medical Center
2023–2026
Al-Makassed Hospital- Jerusalem
2020–2023
Palestine Medical Complex- Ramallah
2019–2020
AL QUDS UNIV, FAC OF MED, ABU-DIS, JERUSALEM, PALESTINE, STATE OF
2009–2013

Research

Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical…
Review · Frontiers in Oncology · 2019 · 51 citations
Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction
Review · Frontiers in Cell and Developmental Biology · 2022 · 28 citations
Road testing new CAR design strategies in multiple myeloma
Review · Frontiers in Immunology · 2022 · 14 citations

Shebli Atrash
8 papers
Prerna Mewawalla
6 papers
Mansi Shah
5 papers
Muhammad Mushtaq
5 papers
OA
Omar Alkharabsheh
5 papers
AH
Alma Habib
4 papers · 4 as a fellow
Anita Mazloom
4 papers
Carmel Awadallah
4 papers · 4 as a resident
Abdullah Khan
3 papers
Barry Paul
3 papers
Ehsan Malek
3 papers
FL
Forat Lutfi
3 papers

Clinical trials

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Site PI · Recruiting · Phase 3
Takeda
2026–2028
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2024–2026